APA (7th ed.) Citation

M, Y., A, T., S, M., R, C., J, T., A, M., . . . LG, L. (2024). Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells. Journal for immunotherapy of cancer, 12(3), . https://doi.org/10.1136/jitc-2023-008744

Chicago Style (17th ed.) Citation

M, Yankelevich, et al. "Targeting Refractory/recurrent Neuroblastoma and Osteosarcoma with Anti-CD3×anti-GD2 Bispecific Antibody Armed T Cells." Journal for Immunotherapy of Cancer 12, no. 3 (2024). https://doi.org/10.1136/jitc-2023-008744.

MLA (9th ed.) Citation

M, Yankelevich, et al. "Targeting Refractory/recurrent Neuroblastoma and Osteosarcoma with Anti-CD3×anti-GD2 Bispecific Antibody Armed T Cells." Journal for Immunotherapy of Cancer, vol. 12, no. 3, 2024, https://doi.org/10.1136/jitc-2023-008744.